President
She will replace
As head of the Office of Science and Technology Policy, Prabhakar will work to “expand our possibilities, solve our toughest challenges, and make the impossible possible,” Biden said in a statement.
If confirmed by the Senate, Prabhakar would be the first woman of color and first immigrant to hold the science adviser’s role.
Her portfolio will include issues ranging from climate change to the physical sciences. Prabhakar, 63, also will play an essential role in Cancer Moonshot 2.0 -- an initiative personally important to Biden that aims to cut the cancer death rate in half over the next 25 years.
Prabhakar will draw on her experience leading the Defense Advanced Research Projects Agency -- a Pentagon entity that develops cutting-edge national security technologies, including precision-guided weapons and stealth technology -- particularly as the administration stands up a new biomedical research accelerator. She led DARPA from 2012 to 2017.
The new biomedical research program -- the Advanced Research Projects Agency for Health, or ARPA-H -- aims to shepherd medical breakthroughs the same way DARPA paved the way for the internet and GPS.
Prabhakar, who served as a DARPA program manager from 1986 to 1993, said during a STAT summit last year that ARPA-H should be separate from the National Institutes of Health, which aligns with a bill (H.R. 5585) the House is expected to consider Wednesday. That position differs from plans the administration already has undertaken to house ARPA-H within the NIH.
Prabhakar clocked nearly 15 years of experience in Silicon Valley between running DARPA during President
She’s currently chief executive of Actuate, a nonprofit that aims to apply a DARPA-like approach to issues including climate change, chronic disease and the use of machine learning without compromising privacy.
Prabhakar would be the fourth woman to lead the OSTP, which has existed since the 1950s.
Lander
To contact the reporters on this story:
To contact the editors responsible for this story:
Kathleen Hunter
© 2022 Bloomberg L.P. All rights reserved. Used with permission.
To read more articles log in.
Learn more about a Bloomberg Law subscription.